nodes	percent_of_prediction	percent_of_DWPC	metapath
Dopamine—COMT—Conjugated Estrogens—osteoporosis	0.247	0.313	CbGbCtD
Dopamine—SLC22A1—Estropipate—osteoporosis	0.121	0.154	CbGbCtD
Dopamine—SLC22A3—Estradiol—osteoporosis	0.0979	0.124	CbGbCtD
Dopamine—SLC22A2—Estradiol—osteoporosis	0.058	0.0734	CbGbCtD
Dopamine—SLC22A1—Estradiol—osteoporosis	0.0504	0.0638	CbGbCtD
Dopamine—CYP1A2—Estropipate—osteoporosis	0.0425	0.0538	CbGbCtD
Dopamine—CYP2C9—Estropipate—osteoporosis	0.0383	0.0485	CbGbCtD
Dopamine—CYP2C19—Cholecalciferol—osteoporosis	0.0237	0.03	CbGbCtD
Dopamine—CYP1A2—Conjugated Estrogens—osteoporosis	0.0201	0.0255	CbGbCtD
Dopamine—CYP2C9—Cholecalciferol—osteoporosis	0.0197	0.025	CbGbCtD
Dopamine—CYP2C19—Estradiol—osteoporosis	0.0191	0.0242	CbGbCtD
Dopamine—CYP2D6—Cholecalciferol—osteoporosis	0.018	0.0228	CbGbCtD
Dopamine—CYP1A2—Estradiol—osteoporosis	0.0176	0.0223	CbGbCtD
Dopamine—CYP2C9—Estradiol—osteoporosis	0.0159	0.0201	CbGbCtD
Dopamine—Azotaemia—Ergocalciferol—osteoporosis	0.00807	0.088	CcSEcCtD
Dopamine—Necrosis—Calcium Acetate—osteoporosis	0.0062	0.0676	CcSEcCtD
Dopamine—Azotaemia—Ibandronate—osteoporosis	0.00498	0.0542	CcSEcCtD
Dopamine—Azotaemia—Pamidronate—osteoporosis	0.0039	0.0425	CcSEcCtD
Dopamine—Azotaemia—Zoledronate—osteoporosis	0.00356	0.0388	CcSEcCtD
Dopamine—Menorrhagia—Ethinyl Estradiol—osteoporosis	0.00303	0.033	CcSEcCtD
Dopamine—Cyanosis—Conjugated Estrogens—osteoporosis	0.00258	0.0281	CcSEcCtD
Dopamine—Bradycardia—Calcium Acetate—osteoporosis	0.00249	0.0271	CcSEcCtD
Dopamine—Necrosis—Conjugated Estrogens—osteoporosis	0.00233	0.0254	CcSEcCtD
Dopamine—Dobutamine—CA2—osteoporosis	0.00213	0.479	CrCbGaD
Dopamine—Extravasation—Conjugated Estrogens—osteoporosis	0.00209	0.0228	CcSEcCtD
Dopamine—Menorrhagia—Estradiol—osteoporosis	0.00198	0.0215	CcSEcCtD
Dopamine—Masoprocol—CYP19A1—osteoporosis	0.00165	0.371	CrCbGaD
Dopamine—Hypertension—Ergocalciferol—osteoporosis	0.00162	0.0177	CcSEcCtD
Dopamine—Atrial fibrillation—Pamidronate—osteoporosis	0.00159	0.0173	CcSEcCtD
Dopamine—Atrial fibrillation—Zoledronate—osteoporosis	0.00145	0.0158	CcSEcCtD
Dopamine—Angina pectoris—Risedronate—osteoporosis	0.00134	0.0146	CcSEcCtD
Dopamine—Vomiting—Calcium Acetate—osteoporosis	0.0011	0.012	CcSEcCtD
Dopamine—Palpitations—Estropipate—osteoporosis	0.00107	0.0116	CcSEcCtD
Dopamine—Nausea—Calcium Acetate—osteoporosis	0.00103	0.0112	CcSEcCtD
Dopamine—Anxiety—Estropipate—osteoporosis	0.00103	0.0112	CcSEcCtD
Dopamine—Palpitations—Ibandronate—osteoporosis	0.00102	0.0112	CcSEcCtD
Dopamine—Hypertension—Ibandronate—osteoporosis	0.001	0.0109	CcSEcCtD
Dopamine—Anxiety—Ibandronate—osteoporosis	0.000984	0.0107	CcSEcCtD
Dopamine—Hypertension—Calcitriol—osteoporosis	0.00098	0.0107	CcSEcCtD
Dopamine—Bradycardia—Zoledronate—osteoporosis	0.00097	0.0106	CcSEcCtD
Dopamine—Anxiety—Calcitriol—osteoporosis	0.000963	0.0105	CcSEcCtD
Dopamine—Nausea—Ergocalciferol—osteoporosis	0.000911	0.00993	CcSEcCtD
Dopamine—Anxiety—Ethinyl Estradiol—osteoporosis	0.000831	0.00906	CcSEcCtD
Dopamine—Hypertension—Risedronate—osteoporosis	0.000825	0.00899	CcSEcCtD
Dopamine—Anxiety—Risedronate—osteoporosis	0.000811	0.00883	CcSEcCtD
Dopamine—Hypertension—Pamidronate—osteoporosis	0.000784	0.00854	CcSEcCtD
Dopamine—Anxiety—Pamidronate—osteoporosis	0.000771	0.0084	CcSEcCtD
Dopamine—Palpitations—Zoledronate—osteoporosis	0.000733	0.00799	CcSEcCtD
Dopamine—Vomiting—Etidronic acid—osteoporosis	0.000725	0.0079	CcSEcCtD
Dopamine—Tachycardia—Pamidronate—osteoporosis	0.000723	0.00788	CcSEcCtD
Dopamine—Hypertension—Zoledronate—osteoporosis	0.000716	0.0078	CcSEcCtD
Dopamine—Headache—Etidronic acid—osteoporosis	0.000714	0.00778	CcSEcCtD
Dopamine—Palpitations—Conjugated Estrogens—osteoporosis	0.000706	0.00769	CcSEcCtD
Dopamine—Anxiety—Zoledronate—osteoporosis	0.000704	0.00767	CcSEcCtD
Dopamine—Dyspnoea—Risedronate—osteoporosis	0.000695	0.00757	CcSEcCtD
Dopamine—Anxiety—Conjugated Estrogens—osteoporosis	0.000678	0.00738	CcSEcCtD
Dopamine—Nausea—Etidronic acid—osteoporosis	0.000677	0.00738	CcSEcCtD
Dopamine—Epinephrine—TNF—osteoporosis	0.000671	0.151	CrCbGaD
Dopamine—Dyspnoea—Pamidronate—osteoporosis	0.000661	0.0072	CcSEcCtD
Dopamine—Tachycardia—Zoledronate—osteoporosis	0.000661	0.0072	CcSEcCtD
Dopamine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000636	0.00693	CcSEcCtD
Dopamine—Vomiting—Estropipate—osteoporosis	0.000627	0.00683	CcSEcCtD
Dopamine—Headache—Estropipate—osteoporosis	0.000618	0.00673	CcSEcCtD
Dopamine—Vomiting—Alendronate—osteoporosis	0.000618	0.00673	CcSEcCtD
Dopamine—Headache—Alendronate—osteoporosis	0.000609	0.00663	CcSEcCtD
Dopamine—Vomiting—Raloxifene—osteoporosis	0.000608	0.00662	CcSEcCtD
Dopamine—Dyspnoea—Zoledronate—osteoporosis	0.000604	0.00658	CcSEcCtD
Dopamine—Vomiting—Ibandronate—osteoporosis	0.000602	0.00655	CcSEcCtD
Dopamine—Headache—Raloxifene—osteoporosis	0.000599	0.00652	CcSEcCtD
Dopamine—Headache—Ibandronate—osteoporosis	0.000593	0.00646	CcSEcCtD
Dopamine—Vomiting—Calcitriol—osteoporosis	0.000589	0.00642	CcSEcCtD
Dopamine—Nausea—Estropipate—osteoporosis	0.000586	0.00639	CcSEcCtD
Dopamine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000581	0.00633	CcSEcCtD
Dopamine—Headache—Calcitriol—osteoporosis	0.00058	0.00632	CcSEcCtD
Dopamine—Nausea—Alendronate—osteoporosis	0.000577	0.00629	CcSEcCtD
Dopamine—Nausea—Raloxifene—osteoporosis	0.000568	0.00618	CcSEcCtD
Dopamine—Palpitations—Estradiol—osteoporosis	0.000565	0.00616	CcSEcCtD
Dopamine—Nausea—Ibandronate—osteoporosis	0.000562	0.00612	CcSEcCtD
Dopamine—Hypertension—Estradiol—osteoporosis	0.000552	0.00601	CcSEcCtD
Dopamine—Nausea—Calcitriol—osteoporosis	0.00055	0.00599	CcSEcCtD
Dopamine—Anxiety—Estradiol—osteoporosis	0.000542	0.00591	CcSEcCtD
Dopamine—Tachycardia—Estradiol—osteoporosis	0.000509	0.00555	CcSEcCtD
Dopamine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000508	0.00554	CcSEcCtD
Dopamine—Headache—Ethinyl Estradiol—osteoporosis	0.000501	0.00546	CcSEcCtD
Dopamine—Vomiting—Risedronate—osteoporosis	0.000496	0.0054	CcSEcCtD
Dopamine—Headache—Risedronate—osteoporosis	0.000488	0.00532	CcSEcCtD
Dopamine—Nausea—Ethinyl Estradiol—osteoporosis	0.000475	0.00518	CcSEcCtD
Dopamine—Vomiting—Pamidronate—osteoporosis	0.000471	0.00513	CcSEcCtD
Dopamine—Dyspnoea—Estradiol—osteoporosis	0.000465	0.00507	CcSEcCtD
Dopamine—Headache—Pamidronate—osteoporosis	0.000464	0.00506	CcSEcCtD
Dopamine—Nausea—Risedronate—osteoporosis	0.000463	0.00505	CcSEcCtD
Dopamine—Nausea—Pamidronate—osteoporosis	0.00044	0.0048	CcSEcCtD
Dopamine—Vomiting—Zoledronate—osteoporosis	0.00043	0.00469	CcSEcCtD
Dopamine—Headache—Zoledronate—osteoporosis	0.000424	0.00462	CcSEcCtD
Dopamine—Vomiting—Conjugated Estrogens—osteoporosis	0.000415	0.00452	CcSEcCtD
Dopamine—Headache—Conjugated Estrogens—osteoporosis	0.000408	0.00445	CcSEcCtD
Dopamine—Nausea—Zoledronate—osteoporosis	0.000402	0.00438	CcSEcCtD
Dopamine—Nausea—Conjugated Estrogens—osteoporosis	0.000387	0.00422	CcSEcCtD
Dopamine—Vomiting—Estradiol—osteoporosis	0.000332	0.00361	CcSEcCtD
Dopamine—Headache—Estradiol—osteoporosis	0.000327	0.00356	CcSEcCtD
Dopamine—Nausea—Estradiol—osteoporosis	0.00031	0.00338	CcSEcCtD
Dopamine—MAOA—Metabolism—CYP19A1—osteoporosis	2.32e-05	0.000203	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—FGA—osteoporosis	2.31e-05	0.000202	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—ENO1—osteoporosis	2.28e-05	0.0002	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—SPP1—osteoporosis	2.28e-05	0.000199	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—ADCY5—osteoporosis	2.28e-05	0.000199	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PTH—osteoporosis	2.28e-05	0.000199	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—POMC—osteoporosis	2.26e-05	0.000198	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PSMA2—osteoporosis	2.25e-05	0.000197	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PSMA5—osteoporosis	2.25e-05	0.000197	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PTHLH—osteoporosis	2.25e-05	0.000197	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—BMP2—osteoporosis	2.25e-05	0.000197	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.25e-05	0.000197	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—RAP1A—osteoporosis	2.24e-05	0.000196	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—IDH2—osteoporosis	2.22e-05	0.000194	CbGpPWpGaD
Dopamine—MAOB—Metabolism—POMC—osteoporosis	2.22e-05	0.000194	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—KL—osteoporosis	2.22e-05	0.000194	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CNR2—osteoporosis	2.22e-05	0.000194	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—IL6R—osteoporosis	2.21e-05	0.000193	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—ADCY5—osteoporosis	2.2e-05	0.000193	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CALCA—osteoporosis	2.2e-05	0.000193	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—FGB—osteoporosis	2.2e-05	0.000192	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NFATC1—osteoporosis	2.18e-05	0.000191	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CALCA—osteoporosis	2.17e-05	0.00019	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—DKK1—osteoporosis	2.17e-05	0.00019	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—POMC—osteoporosis	2.16e-05	0.000189	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PTHLH—osteoporosis	2.15e-05	0.000188	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—BMP2—osteoporosis	2.15e-05	0.000188	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—POMC—osteoporosis	2.15e-05	0.000188	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PSMA2—osteoporosis	2.12e-05	0.000186	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PSMA5—osteoporosis	2.12e-05	0.000186	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—POMC—osteoporosis	2.12e-05	0.000185	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—IL6R—osteoporosis	2.11e-05	0.000185	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—FGB—osteoporosis	2.1e-05	0.000184	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—OXCT1—osteoporosis	2.09e-05	0.000183	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CA2—osteoporosis	2.09e-05	0.000183	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CYP27A1—osteoporosis	2.09e-05	0.000183	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—WNT1—osteoporosis	2.09e-05	0.000183	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—IRS2—osteoporosis	2.06e-05	0.00018	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—IDH2—osteoporosis	2.04e-05	0.000179	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—MGLL—osteoporosis	2.03e-05	0.000178	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—ACP5—osteoporosis	2.03e-05	0.000178	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PSMA2—osteoporosis	2.03e-05	0.000178	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PSMA5—osteoporosis	2.03e-05	0.000178	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—FGA—osteoporosis	2.03e-05	0.000178	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—IDH2—osteoporosis	2.02e-05	0.000177	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—LEP—osteoporosis	2.02e-05	0.000177	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.01e-05	0.000176	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—ADCY5—osteoporosis	2e-05	0.000175	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—KL—osteoporosis	2e-05	0.000175	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CALCA—osteoporosis	1.98e-05	0.000173	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—KL—osteoporosis	1.97e-05	0.000173	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—CYP19A1—osteoporosis	1.96e-05	0.000172	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—POMC—osteoporosis	1.95e-05	0.000171	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—POMC—osteoporosis	1.93e-05	0.000169	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—ESR1—osteoporosis	1.93e-05	0.000169	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—POMC—osteoporosis	1.92e-05	0.000168	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.92e-05	0.000168	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.92e-05	0.000168	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CYP27A1—osteoporosis	1.9e-05	0.000167	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—IL6R—osteoporosis	1.9e-05	0.000166	CbGpPWpGaD
Dopamine—MAOA—Metabolism—ADCY5—osteoporosis	1.89e-05	0.000166	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CALCA—osteoporosis	1.89e-05	0.000166	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—TPI1—osteoporosis	1.89e-05	0.000165	CbGpPWpGaD
Dopamine—MAOA—Metabolism—GPX1—osteoporosis	1.89e-05	0.000165	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PTHLH—osteoporosis	1.89e-05	0.000165	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—BMP2—osteoporosis	1.89e-05	0.000165	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—POMC—osteoporosis	1.88e-05	0.000164	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—IL6R—osteoporosis	1.88e-05	0.000164	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ACP5—osteoporosis	1.87e-05	0.000164	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ACP5—osteoporosis	1.85e-05	0.000162	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—FGB—osteoporosis	1.85e-05	0.000162	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—POMC—osteoporosis	1.84e-05	0.000162	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.83e-05	0.00016	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—CYP19A1—osteoporosis	1.83e-05	0.00016	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—ADCY5—osteoporosis	1.82e-05	0.000159	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—IRS1—osteoporosis	1.8e-05	0.000158	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—KL—osteoporosis	1.8e-05	0.000157	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PSMA2—osteoporosis	1.78e-05	0.000156	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PSMA5—osteoporosis	1.78e-05	0.000156	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—P4HB—osteoporosis	1.78e-05	0.000155	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—SPP1—osteoporosis	1.76e-05	0.000154	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—POMC—osteoporosis	1.75e-05	0.000153	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—GAPDH—osteoporosis	1.74e-05	0.000153	CbGpPWpGaD
Dopamine—MAOA—Metabolism—MTHFR—osteoporosis	1.74e-05	0.000152	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—ADCY5—osteoporosis	1.74e-05	0.000152	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—TPI1—osteoporosis	1.74e-05	0.000152	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—POMC—osteoporosis	1.73e-05	0.000152	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—IDH2—osteoporosis	1.73e-05	0.000151	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—TPI1—osteoporosis	1.72e-05	0.000151	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—KL—osteoporosis	1.72e-05	0.00015	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—IL6R—osteoporosis	1.71e-05	0.00015	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—RAP1A—osteoporosis	1.7e-05	0.000149	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—IL6R—osteoporosis	1.69e-05	0.000148	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—SPP1—osteoporosis	1.68e-05	0.000147	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—POMC—osteoporosis	1.68e-05	0.000147	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—IGF1—osteoporosis	1.67e-05	0.000146	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CALCA—osteoporosis	1.66e-05	0.000145	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—IL6R—osteoporosis	1.63e-05	0.000143	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—P4HB—osteoporosis	1.63e-05	0.000143	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CYP27A1—osteoporosis	1.63e-05	0.000142	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—POMC—osteoporosis	1.62e-05	0.000142	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—P4HB—osteoporosis	1.62e-05	0.000142	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—GAPDH—osteoporosis	1.6e-05	0.00014	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—ADCY5—osteoporosis	1.6e-05	0.00014	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—GPX1—osteoporosis	1.6e-05	0.00014	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—GAPDH—osteoporosis	1.59e-05	0.000139	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—IRS2—osteoporosis	1.59e-05	0.000139	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ACP5—osteoporosis	1.58e-05	0.000139	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—ADCY5—osteoporosis	1.56e-05	0.000137	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.56e-05	0.000137	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—RAP1A—osteoporosis	1.56e-05	0.000137	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—LEP—osteoporosis	1.55e-05	0.000136	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—RAP1A—osteoporosis	1.55e-05	0.000135	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—ADCY5—osteoporosis	1.54e-05	0.000135	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—IRS2—osteoporosis	1.52e-05	0.000133	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—SPP1—osteoporosis	1.51e-05	0.000133	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—KL—osteoporosis	1.51e-05	0.000132	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—SPP1—osteoporosis	1.49e-05	0.000131	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—ADCY5—osteoporosis	1.49e-05	0.000131	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—LEP—osteoporosis	1.49e-05	0.00013	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—GPX1—osteoporosis	1.49e-05	0.00013	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—ESR1—osteoporosis	1.48e-05	0.00013	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.48e-05	0.00013	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—MTHFR—osteoporosis	1.47e-05	0.000129	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—TPI1—osteoporosis	1.47e-05	0.000129	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—POMC—osteoporosis	1.47e-05	0.000129	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—IL6R—osteoporosis	1.43e-05	0.000126	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—ESR1—osteoporosis	1.42e-05	0.000124	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—ADCY5—osteoporosis	1.41e-05	0.000123	CbGpPWpGaD
Dopamine—MAOA—Metabolism—POMC—osteoporosis	1.39e-05	0.000122	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—IRS1—osteoporosis	1.39e-05	0.000121	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—P4HB—osteoporosis	1.38e-05	0.000121	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—MTHFR—osteoporosis	1.37e-05	0.00012	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—ENO1—osteoporosis	1.37e-05	0.00012	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—IRS2—osteoporosis	1.37e-05	0.00012	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—SPP1—osteoporosis	1.36e-05	0.000119	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—GAPDH—osteoporosis	1.36e-05	0.000119	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PSMA2—osteoporosis	1.35e-05	0.000118	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PSMA5—osteoporosis	1.35e-05	0.000118	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—IRS2—osteoporosis	1.35e-05	0.000118	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.35e-05	0.000118	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—ADCY5—osteoporosis	1.35e-05	0.000118	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—LEP—osteoporosis	1.34e-05	0.000117	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—POMC—osteoporosis	1.34e-05	0.000117	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—IRS1—osteoporosis	1.33e-05	0.000116	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—RAP1A—osteoporosis	1.32e-05	0.000116	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—LEP—osteoporosis	1.32e-05	0.000116	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—IL6R—osteoporosis	1.3e-05	0.000114	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—SPP1—osteoporosis	1.3e-05	0.000114	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—IGF1—osteoporosis	1.28e-05	0.000112	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—ESR1—osteoporosis	1.28e-05	0.000112	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—POMC—osteoporosis	1.28e-05	0.000112	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—IL6—osteoporosis	1.27e-05	0.000112	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—ESR1—osteoporosis	1.26e-05	0.000111	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ENO1—osteoporosis	1.26e-05	0.00011	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ENO1—osteoporosis	1.25e-05	0.00011	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—IL6R—osteoporosis	1.25e-05	0.000109	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PSMA2—osteoporosis	1.24e-05	0.000109	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PSMA5—osteoporosis	1.24e-05	0.000109	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PSMA5—osteoporosis	1.23e-05	0.000108	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PSMA2—osteoporosis	1.23e-05	0.000108	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—IRS2—osteoporosis	1.23e-05	0.000108	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—IGF1—osteoporosis	1.23e-05	0.000108	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—LEP—osteoporosis	1.2e-05	0.000105	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—IRS1—osteoporosis	1.2e-05	0.000105	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—ADCY5—osteoporosis	1.18e-05	0.000103	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—IRS1—osteoporosis	1.18e-05	0.000103	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—POMC—osteoporosis	1.18e-05	0.000103	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IRS2—osteoporosis	1.18e-05	0.000103	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.15e-05	0.000101	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—LEP—osteoporosis	1.15e-05	0.000101	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—POMC—osteoporosis	1.15e-05	0.000101	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—ESR1—osteoporosis	1.15e-05	0.000101	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—SPP1—osteoporosis	1.14e-05	0.0001	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—POMC—osteoporosis	1.14e-05	9.94e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—IL6R—osteoporosis	1.12e-05	9.83e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—IL6R—osteoporosis	1.11e-05	9.7e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—IGF1—osteoporosis	1.11e-05	9.69e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—ESR1—osteoporosis	1.1e-05	9.63e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—POMC—osteoporosis	1.1e-05	9.61e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CYP19A1—osteoporosis	1.1e-05	9.6e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—IGF1—osteoporosis	1.09e-05	9.56e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—IRS1—osteoporosis	1.07e-05	9.41e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ENO1—osteoporosis	1.07e-05	9.36e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PSMA2—osteoporosis	1.05e-05	9.22e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PSMA5—osteoporosis	1.05e-05	9.22e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—POMC—osteoporosis	1.03e-05	9.06e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IRS2—osteoporosis	1.03e-05	9.05e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IRS1—osteoporosis	1.03e-05	9e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—LEP—osteoporosis	1.01e-05	8.86e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—IL6R—osteoporosis	1.01e-05	8.84e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.01e-05	8.83e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—MYC—osteoporosis	1e-05	8.77e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CYP19A1—osteoporosis	1e-05	8.76e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—TGFB1—osteoporosis	9.99e-06	8.75e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—IGF1—osteoporosis	9.95e-06	8.71e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—POMC—osteoporosis	9.9e-06	8.67e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—IL6—osteoporosis	9.82e-06	8.6e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—ESR1—osteoporosis	9.66e-06	8.46e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IL6R—osteoporosis	9.65e-06	8.45e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IGF1—osteoporosis	9.52e-06	8.34e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—IL6—osteoporosis	9.4e-06	8.23e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IRS1—osteoporosis	9.02e-06	7.9e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—ADCY5—osteoporosis	8.96e-06	7.85e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—GPX1—osteoporosis	8.93e-06	7.82e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—POMC—osteoporosis	8.69e-06	7.61e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CYP19A1—osteoporosis	8.54e-06	7.48e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IL6R—osteoporosis	8.48e-06	7.42e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—IL6—osteoporosis	8.47e-06	7.41e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IGF1—osteoporosis	8.36e-06	7.32e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—IL6—osteoporosis	8.35e-06	7.31e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ADCY5—osteoporosis	8.24e-06	7.22e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—MTHFR—osteoporosis	8.24e-06	7.22e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—GPX1—osteoporosis	8.21e-06	7.19e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ADCY5—osteoporosis	8.17e-06	7.15e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—GPX1—osteoporosis	8.14e-06	7.13e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—MYC—osteoporosis	7.72e-06	6.76e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TGFB1—osteoporosis	7.7e-06	6.74e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—IL6—osteoporosis	7.61e-06	6.66e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—MTHFR—osteoporosis	7.58e-06	6.64e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—IL6—osteoporosis	7.53e-06	6.59e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—MTHFR—osteoporosis	7.51e-06	6.58e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—MYC—osteoporosis	7.39e-06	6.47e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TGFB1—osteoporosis	7.37e-06	6.46e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—IL6—osteoporosis	7.28e-06	6.37e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ADCY5—osteoporosis	6.98e-06	6.11e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—GPX1—osteoporosis	6.96e-06	6.09e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MYC—osteoporosis	6.65e-06	5.83e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TGFB1—osteoporosis	6.64e-06	5.81e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—POMC—osteoporosis	6.59e-06	5.77e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MYC—osteoporosis	6.56e-06	5.75e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TGFB1—osteoporosis	6.55e-06	5.73e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—MTHFR—osteoporosis	6.42e-06	5.62e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—IL6—osteoporosis	6.39e-06	5.6e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—POMC—osteoporosis	6.06e-06	5.31e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—POMC—osteoporosis	6.01e-06	5.26e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MYC—osteoporosis	5.98e-06	5.24e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TGFB1—osteoporosis	5.97e-06	5.22e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—IL6—osteoporosis	5.8e-06	5.08e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MYC—osteoporosis	5.72e-06	5.01e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TGFB1—osteoporosis	5.71e-06	5e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—IL6—osteoporosis	5.56e-06	4.86e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—POMC—osteoporosis	5.14e-06	4.5e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MYC—osteoporosis	5.02e-06	4.4e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TGFB1—osteoporosis	5.01e-06	4.39e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—IL6—osteoporosis	5e-06	4.38e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—IL6—osteoporosis	4.93e-06	4.32e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—IL6—osteoporosis	4.5e-06	3.94e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IL6—osteoporosis	4.3e-06	3.77e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IL6—osteoporosis	3.78e-06	3.31e-05	CbGpPWpGaD
